A novel therapeutic modality using CRISPR-engineered dendritic cells to treat allergies
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 273, 120798
Abstract
No abstract availableKeywords
Funding Information
- Korea Ministry of Health and Welfare
- Korea Institute of Science and Technology
- National Research Foundation of Korea
- Korea Ministry of Science and ICT
This publication has 63 references indexed in Scilit:
- Allergen Recognition by Innate Immune Cells: Critical Role of Dendritic and Epithelial CellsFrontiers in Immunology, 2013
- MIG (CXCL9), IP-10 (CXCL10) and I-TAC (CXCL11) concentrations after nasal allergen challenge in patients with allergic rhinitisArchives of Medical Science, 2013
- Multivesicular Body MorphogenesisAnnual Review of Cell and Developmental Biology, 2012
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012
- The Glycosylation Pattern of Common Allergens: The Recognition and Uptake of Der p 1 by Epithelial and Dendritic Cells Is Carbohydrate DependentPLOS ONE, 2012
- Retagging Identifies Dendritic Cell-specific Intercellular Adhesion Molecule-3 (ICAM3)-grabbing Non-integrin (DC-SIGN) Protein as a Novel Receptor for a Major Allergen from House Dust MiteJournal of Biological Chemistry, 2012
- Integrative genomics viewerNature Biotechnology, 2011
- The Mannose Receptor Mediates the Uptake of Diverse Native Allergens by Dendritic Cells and Determines Allergen-Induced T Cell Polarization through Modulation of IDO ActivityThe Journal of Immunology, 2010
- Inhibitors of clathrin-dependent endocytosis enhance TGFβ signaling and responsesJournal of Cell Science, 2009
- House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cellsNature Medicine, 2009